Denali Therapeutics

$180.0K revenue • 1 employees • 161 Oyster Point Blvd, South San Francisco, CA, 94080, United States

Last Updated Feb 19, 2026

Company Overview

Company Name

Denali Therapeutics

Address

161 Oyster Point Blvd, South San Francisco, CA, 94080, United States

Approx. Annual Revenue

$0.2M

Employees

1

Established

2015

About Denali Therapeutics

Denali Therapeutics is a biopharmaceutical company headquartered in San Francisco, CA, with approximately 201 employees. The company is dedicated to developing treatments for neurodegenerative and lysosomal storage diseases, leveraging its expertise in the genetic, pathological, and cellular processes underlying these conditions.

Business Profile

Read from the Denali Therapeutics website on Oct 13, 2026. Hover an item to see the exact wording it came from.

About the website

Website quality (AI-assessed)
8/10 · Current content and clear navigation; Contact form and careers listed
Footer copyright year
2024

Biotech & Life Sciences Companies near South San Francisco, CA

Browse all Biotech & Life Sciences companies in California →

Frequently Asked Questions about Denali Therapeutics

Categories

Technologies Used

Social Profiles

Key Decision Makers

John Karris Sr. Clinical Outsourcing Manager
LinkedIn
Winnie Chang Clinical Trial Associate
LinkedIn
Kelsey O'Day Clinical Trial Manager
LinkedIn
Yin Liang Clinical Trial Manager
LinkedIn